Inclisiran News
Inclisiran currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Inclisiran with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet: in combination with a statin or statin with...
- Evidence level: L5
- Predicted indications (20):
- potassium deficiency disease (99.9%)
- esophageal disease (99.9%)
- atypical coarctation of aorta (99.9%)
- migraine disorder (99.8%)
- non-syndromic esophageal malformation (99.8%)
- migraine with brainstem aura (99.8%)
- migraine with or without aura, susceptibility to (99.8%)
- aortic malformation (99.8%)
- esophageal ulcer (99.7%)
- Raynaud disease (99.7%)
- peptic esophagitis (99.7%)
- cauda equina syndrome (99.7%)
- gastrin secretion abnormality (99.7%)
- ulerythema ophryogenesis (99.6%)
- irritable bowel syndrome (99.6%)
- atrophoderma vermiculata (99.5%)
- peptic ulcer disease (99.5%)
- esophageal diverticulosis (99.5%)
- phaeochromocytoma (99.5%)
- dyskinesia of esophagus (99.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.